All data are based on the daily closing price as of November 18, 2026
m
Microbio
4128.TWO
0.39 USD
-0.01
-2.50%
Overview
Last close
0.39 usd
Market cap
229.50M usd
52 week high
0.97 usd
52 week low
0.39 usd
Target price
N/A usd
Valuation
P/E
23.3636
Forward P/E
1111.1111
Price/Sales
3.8455
Price/Book Value
0.8684
Enterprise Value
182.60M usd
EV/Revenue
3.0862
EV/EBITDA
17.1556
Key financials
Revenue TTM
59.68M usd
Gross Profit TTM
23.64M usd
EBITDA TTM
-11.25M usd
Earnings per Share
0.02 usd
Dividend
N/A usd
Total assets
393.69M usd
Net debt
N/A usd
About
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.